Barely Significant
← all excerpts

Development of the first geldanamycin-based HSP90 degraders.

Front Chem · 2023 · PMC10336212 · PMID 37448856

1
hedged sentence
closest p
boldest claim

The sentences

a weak trendno p-value reported
Increasing the concentration of pomalidomide resulted in a gradual rescue of HSP90α degradation, while a weak trend in the HSP90β rescue was noticed ( Figure 3B ).

also in 220 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.